Skip to main content
Andrew Mammen, MD, Neurology, Baltimore, MD

Andrew L Mammen MD

Neurology•Baltimore, MD

Neuromuscular Medicine, Neurophysiology

Adjunct Associate Professor of Neurology, Adjunct Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Join to View Full Profile

  • 4940 Eastern AveBaltimore, MD 21224

  • Phone+1 410-550-5624

Dr. Mammen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Mammen's Full ProfileAlready have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2004 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 2001 - 2004
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2000 - 2001
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2000

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2004 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Neuromuscular Medicine
    American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Press Mentions

  • Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy
    Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing MyopathyJune 4th, 2019
  • Update on Myositis
    Update on MyositisOctober 25th, 2018
  • Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis Phenotype
    Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis PhenotypeJanuary 23rd, 2017
  • Join now to see all

Professional Memberships

External Links

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Andrew Mammen, Dr. Andrew Mammen, MD, Dr. A Mammen, Dr. Andrew L Mammen